000			02068 a2200625 4500
005			20250517235238.0
264		0	_c20180917
008			201809s 0 0 eng d
022			_a1791-7530
024	7		_a10.21873/anticanres.12885 _2doi
040			_aNLM _beng _cNLM
100	1		_aHarada, Noboru
245	0	0	_aSerum Asunaprevir and Daclatasvir Concentrations and Outcomes in Patients with Recurrent Hepatitis C Who Have Undergone Living Donor Liver Transplantation. _h[electronic resource]
260			_bAnticancer research _cSep 2018
300			_a5513-5520 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aCarbamates
650	0	4	_aDrug Interactions
650	0	4	_aDrug Monitoring
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xdrug effects
650	0	4	_aHepatitis C _xblood
650	0	4	_aHumans
650	0	4	_aImidazoles _xadministration & dosage
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aIsoquinolines _xadministration & dosage
650	0	4	_aLiver Transplantation _xadverse effects
650	0	4	_aLiving Donors
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProspective Studies
650	0	4	_aPyrrolidines
650	0	4	_aRecurrence
650	0	4	_aSulfonamides _xadministration & dosage
650	0	4	_aTacrolimus _xadverse effects
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aValine _xanalogs & derivatives
650	0	4	_aViral Load
700	1		_aYoshizumi, Tomoharu
700	1		_aIkegami, Toru
700	1		_aItoh, Shinji
700	1		_aFurusho, Norihiro
700	1		_aKato, Masaki
700	1		_aShimoda, Shinji
700	1		_aFukuhara, Takasuke
700	1		_aSoejima, Yuji
700	1		_aMaehara, Yoshihiko
773	0		_tAnticancer research _gvol. 38 _gno. 9 _gp. 5513-5520
856	4	0	_uhttps://doi.org/10.21873/anticanres.12885 _zAvailable from publisher's website
999			_c28814850 _d28814850